Federated Hermes, Inc. Astrazeneca PLC Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Federated Hermes, Inc. holds 261,124 shares of AZN stock, worth $17.5 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

261,124

Previous 276,481 5.55%

Holding current value

$17.5 Million

Previous $21.6 Million 5.64%

% of portfolio

0.05%

Previous 0.05%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$76.67 - $87.62 $1.18 Million - $1.35 Million	-15,357 Reduced 5.55%	261,124 $20.3 Million
Q2 2024 Aug 08, 2024	BUY	$66.81 - $80.83 $438,808 - $530,891	6,568 Added 2.43%	276,481 $21.6 Million
Q1 2024 May 14, 2024	SELL	$61.03 - $69.57 $1.2 Million - $1.37 Million	-19,664 Reduced 6.79%	269,913 $18.3 Million
Q4 2023 Jan 31, 2024	SELL	$61.89 - $69.28 $450,435 - $504,219	-7,278 Reduced 2.45%	289,577 $19.5 Million
Q3 2023 Nov 13, 2023	BUY	$64.85 - $71.7 $2,010 - $2,222	31 Added 0.01%	296,855 $20.1 Million
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $33,836 - $36,692	484 Added 0.16%	296,824 $21.2 Million
Q1 2023 May 08, 2023	SELL	$63.15 - $71.6 $9.46 Million - $10.7 Million	-149,846 Reduced 33.58%	296,340 $20.6 Million
Q4 2022 Feb 13, 2023	SELL	$54.21 - $70.44 $2,114 - $2,747	-39 Reduced 0.01%	446,186 $30.3 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $1.17 Million - $2.99 Million	22,002 Added 5.19%	446,225 $24.5 Million
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $14.4 Million - $17.3 Million	-243,740 Reduced 36.49%	424,223 $28 Million
Q1 2022 May 13, 2022	SELL	$55.72 - $67.12 $28.3 Million - $34.1 Million	-507,972 Reduced 43.2%	667,963 $44.3 Million
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $15 Million - $17.7 Million	277,619 Added 30.9%	1,175,935 $68.5 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $1.02 Million - $1.12 Million	18,414 Added 2.09%	898,316 $54 Million
Q2 2021 Aug 16, 2021	BUY	$48.42 - $60.18 $11 Million - $13.6 Million	226,164 Added 34.6%	879,902 $52.7 Million
Q1 2021 May 13, 2021	BUY	$47.16 - $54.44 $288,760 - $333,336	6,123 Added 0.95%	653,738 $32.5 Million
Q4 2020 Feb 12, 2021	SELL	$48.52 - $58.02 $3 Million - $3.59 Million	-61,823 Reduced 8.71%	647,615 $32.4 Million
Q3 2020 Nov 12, 2020	SELL	$53.07 - $61.1 $1.32 Million - $1.52 Million	-24,815 Reduced 3.38%	709,438 $38.9 Million
Q2 2020 Aug 13, 2020	BUY	$43.1 - $55.31 $439,102 - $563,498	10,188 Added 1.41%	734,253 $38.8 Million
Q1 2020 May 13, 2020	BUY	$37.79 - $51.33 $7.9 Million - $10.7 Million	209,080 Added 40.6%	724,065 $32.3 Million
Q4 2019 Feb 14, 2020	BUY	$42.46 - $50.46 $9.89 Million - $11.8 Million	233,019 Added 82.64%	514,985 $25.7 Million
Q3 2019 Nov 14, 2019	SELL	$40.12 - $45.47 $3.66 Million - $4.15 Million	-91,329 Reduced 24.47%	281,966 $12.6 Million
Q2 2019 Aug 14, 2019	SELL	$37.28 - $41.68 $2.06 Million - $2.31 Million	-55,378 Reduced 12.92%	373,295 $15.4 Million
Q1 2019 May 10, 2019	SELL	$35.49 - $43.02 $94.6 Million - $115 Million	-2,664,304 Reduced 86.14%	428,673 $17.3 Million
Q4 2018 Feb 13, 2019	BUY	$36.86 - $41.49 $23.9 Million - $27 Million	649,616 Added 26.59%	3,092,977 $117 Million
Q3 2018 Nov 13, 2018	SELL	$34.76 - $39.72 $45.8 Million - $52.3 Million	-1,316,521 Reduced 35.01%	2,443,361 $96.7 Million
Q2 2018 Aug 10, 2018	SELL	$34.55 - $37.05 $17.3 Million - $18.5 Million	-499,844 Reduced 11.73%	3,759,882 $132 Million
Q1 2018 May 09, 2018	SELL	$32.97 - $36.63 $35.5 Million - $39.4 Million	-1,075,242 Reduced 20.15%	4,259,726 $149 Million
Q4 2017 Feb 14, 2018	BUY	$32.09 - $34.78 $54,938 - $59,543	1,712 Added 0.03%	5,334,968 $0
Q3 2017 Nov 13, 2017	BUY	$28.96 - $34.0 $154 Million - $181 Million	5,333,256	5,333,256 $181 Million

Others Institutions Holding AZN

# of Institutions

1,360

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $208B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Astrazeneca PLC Transaction History